Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Polycythemia Vera × imetelstat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Thrombocythemia, Essential 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Hepatoblastoma 1 Gliosarcoma 1 Glioblastoma 1 Ependymoma 1 Breast Neoplasms 1 Brain Stem Neoplasms 1 Astrocytoma 1

Interventions

fludarabine phosphate 17 Cyclophosphamide 15 Whole-Body Irradiation 10 Peripheral Blood Stem Cell Transplantation 10 ruxolitinib 9 Mycophenolic Acid 9 Busulfan 9 Tacrolimus 8 fludarabine 7 Radiotherapy 5 Methotrexate 5 Cyclosporine 5 Aspirin 5 Melphalan 4 Imatinib Mesylate 4 Biopsy 4 Antilymphocyte Serum 4 peginterferon alfa-2a 3 givinostat hydrochloride 3 givinostat 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Decitabine 3 bomedemstat 2 Surveys and Questionnaires 2 Methylprednisolone 2 Lenalidomide 2 Filgrastim 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01243073 2016-01-26

ET/PV

Geron Corporation

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon ⚡